Changes in use of glucose-lowering drugs and physician responsibility: A Danish nationwide study

被引：0
|
作者：
Pottegard, Anton [1 ]
Thomsen, Reimar [2 ]
Andersen, Jacob Harbo [1 ]
Sondergaard, Jens [3 ]
Vilsboll, Tina [4 ]
机构：
[1] Univ Southern Denmark, Odense, Denmark
[2] Aarhus Univ, Aarhus, Denmark
[3] Univ Southern Denmark, Dept Publ Hlth, Res Unit Gen Practice, Odense C, Denmark
[4] Univ Copenhagen, Gentofte Hosp, Ctr Diabet Res, Hellerup, Denmark
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
416
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [1] Changes in the use of glucose-lowering drugs: A Danish nationwide study
    Pottegard, Anton
    Andersen, Jacob H.
    Sondergaard, Jens
    Thomsen, Reimar W.
    Vilsboll, Tina
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 1002 - 1010
  • [2] Dramatic changes in use of glucose-lowering drugs in Denmark from 2005 through 2021: a nationwide study
    Vilsboll, T.
    Andersen, J. H.
    Sondergaard, J.
    Thomsen, R. W.
    Pottegaard, A.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S297 - S297
  • [3] Age discrepencies in the use of glucose-lowering medications: a nationwide cohort study
    Johansson, K.
    Petersen, T.
    Christensen, M.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S95 - S96
  • [4] Sarcopenia with glucose-lowering drugs
    Reactions Weekly, 2021, 1875 (1) : 12 - 12
  • [5] Use of oral glucose-lowering drugs in a healthcare area
    Garcia de Paredes Esteban, Juan Carlos
    Mora Herrera, Cristina
    REVISTA ESPANOLA DE SALUD PUBLICA, 2021, 95
  • [6] Use of glucose-lowering drugs in Hungary between 2008 and 2017: the increasing use of novel glucose-lowering drug groups
    Csatordai, M.
    Benko, R.
    Matuz, M.
    Bor, A.
    Lengyel, C.
    Doro, P.
    DIABETIC MEDICINE, 2019, 36 (12) : 1612 - 1620
  • [7] Comparison of glucose-lowering drugs
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (09): : 736 - 736
  • [8] Real-world use of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019
    Funck, Kristian L.
    Knudsen, Jakob S.
    Hansen, Troels K.
    Thomsen, Reimar W.
    Grove, Erik L.
    DIABETES OBESITY & METABOLISM, 2021, 23 (02): : 520 - 529
  • [9] Pharmacogenetics of novel glucose-lowering drugs
    Wolfgang Rathmann
    Brenda Bongaerts
    Diabetologia, 2021, 64 : 1201 - 1212
  • [10] Pharmacogenetics of novel glucose-lowering drugs
    Rathmann, Wolfgang
    Bongaerts, Brenda
    DIABETOLOGIA, 2021, 64 (06) : 1201 - 1212
12345